Pharmacogenomics Market Scope And Analysis

  • Report Code : TIPRE00007564
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 239
Buy Now

Pharmacogenomics Market Analysis 2021 to 2031

Buy Now

Pharmacogenomics Market Report Pharmacogenomics Market Size and Share Pharmacogenomics Market Scope and Analysis

Pharmacogenomics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.09 Billion
Market Size by 2028 US$ 14.11 Billion
Global CAGR (2021 - 2028) 10.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • PCR
  • Sequencing
  • Microarray
  • Gel Electrophoresis
  • Mass Spectrometry
By Application
  • Drug Discovery
  • Oncology
  • Neurology and Psychiatry
  • Pain Management
  • Cardiovascular Diseases
By End User
  • Hospitals and Clinics
  • Biopharmaceutical Companies
  • CROs and CDMOs
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann la Roche Ltd
  • Abbott
  • Oxford Nanopore Technologies
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • QIAGEN
  • Agilent Technologies Inc
  • Myriad Genetics Inc
  • Admera Health